191 related articles for article (PubMed ID: 30565221)
1. Esomeprazole-induced ashy dermatosis-like drug eruptions.
Chang HC; Chang YS; Wang KH; Cheng T; Tsai HH
Australas J Dermatol; 2019 Aug; 60(3):e232-e233. PubMed ID: 30565221
[No Abstract] [Full Text] [Related]
2. Sticky Palms Following Use of Proton-Pump Inhibitors.
Alkeraye S; Baclet Y; Delaporte E
JAMA Dermatol; 2016 Jun; 152(6):722-3. PubMed ID: 26962767
[No Abstract] [Full Text] [Related]
3. Esomeprazole fixed drug eruption.
Salloum A; Nasr D; Maalouf D
Contact Dermatitis; 2020 May; 82(5):334-335. PubMed ID: 31967328
[No Abstract] [Full Text] [Related]
4. Letter: proton pump inhibitors, hypergastrinaemia and the risk of gastric neoplasia.
Waldum HL; Hauso Ø; Fossmark R
Aliment Pharmacol Ther; 2015 Aug; 42(3):389. PubMed ID: 26147114
[No Abstract] [Full Text] [Related]
5. Ashy dermatosis (erythema dyschromicum perstans) induced by omeprazole: a report of three cases.
Chua S; Chan MM; Lee HY
Int J Dermatol; 2015 Oct; 54(10):e435-6. PubMed ID: 26146873
[No Abstract] [Full Text] [Related]
6. Esomeprazole induced galactorrhea: a novel side effect.
Pipaliya N; Solanke D; Rathi C; Patel R; Ingle M; Sawant P
Clin J Gastroenterol; 2016 Feb; 9(1):13-6. PubMed ID: 26661629
[TBL] [Abstract][Full Text] [Related]
7. A case report of fixed drug eruption caused by several drugs because of cross-reactivity and co-sensitization.
Sobrino-García M; Gómez-Cardeñosa A; Moreno-Rodilla E; Muñoz-Bellido FJ; Lázaro-Sastre M; Dávila I
Contact Dermatitis; 2019 Jan; 80(1):56-57. PubMed ID: 30246872
[No Abstract] [Full Text] [Related]
8. Agranulocytosis induced by proton pump inhibitors.
Dury S; Nardi J; Gozalo C; Lebargy F; Deslee G
J Clin Gastroenterol; 2012; 46(10):859. PubMed ID: 22240865
[TBL] [Abstract][Full Text] [Related]
9. Succession of duodenal polypoid lesion.
Lin HJ; Chang CW; Chen MJ
Gastroenterology; 2015 May; 148(5):e1-2. PubMed ID: 25824346
[No Abstract] [Full Text] [Related]
10. [Lupus erythematosus and proto-pump inhibitors].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2014 Mar; 141(3):252-3. PubMed ID: 24635967
[No Abstract] [Full Text] [Related]
11. Esomeprazole-induced irritability.
Celikbilek A; Celikbilek M; Akyol L; Pirti I
Acta Neurol Belg; 2014 Sep; 114(3):251-2. PubMed ID: 23975557
[No Abstract] [Full Text] [Related]
12. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
[TBL] [Abstract][Full Text] [Related]
13. [Esomeprazol-induced cutaneous lupus erythematosus].
Gliem N; Broekaert SMC; Seitz CS; Schön MP; Ellenrieder V
Z Gastroenterol; 2017 Sep; 55(9):861-865. PubMed ID: 29186640
[TBL] [Abstract][Full Text] [Related]
14. [Rhabdomyolysis associated with long-term treatment of esomeprazole].
Nishikawa J; Hosokawa A; Fuchino M; Takatori S; Iwamoto M; Kashii Y; Bando T; Shimizu T; Minemura M; Sugiyama T
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(3):299-304. PubMed ID: 29526982
[TBL] [Abstract][Full Text] [Related]
15. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26422093
[TBL] [Abstract][Full Text] [Related]
16. Esomeprazole: a proton pump inhibitor.
Vachhani R; Olds G; Velanovich V
Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
[TBL] [Abstract][Full Text] [Related]
17. Nonpigmented fixed drug eruption induced by esomeprazole.
Morais P; Baudrier T; Mota A; Cunha AP; Cadinha S; Barros AM; Azevedo F
Cutan Ocul Toxicol; 2010 Sep; 29(3):217-20. PubMed ID: 20470240
[TBL] [Abstract][Full Text] [Related]
18. The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.
Xiao YL; Nie YQ; Hou XH; Xie PY; Fang JY; Yuan YZ; Zhou LY; Zhao NQ; Chen MH
J Dig Dis; 2013 Sep; 14(9):463-8. PubMed ID: 23659834
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
[TBL] [Abstract][Full Text] [Related]
20. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
Vakil NB; Shaker R; Johnson DA; Kovacs T; Baerg RD; Hwang C; D'Amico D; Hamelin B
Aliment Pharmacol Ther; 2001 Jul; 15(7):927-35. PubMed ID: 11421866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
